The SA Journal Diabetes & Vascular Disease Vol 14 No 2 (December 2017)

48 / 48

For further product information contact PHARMA DYNAMICS P O Box 30958 Tokai Cape Town 7966
Tel 021 707 7000 Fax 021 701 5898 Email CUSTOMER CARE LINE 0860 PHARMA (742 762)
Carzin XL. Each film coated tablet contains 4 mg doxazosin. Reg. No.: RSA S3 41/7.1/0557. NAM NS2 10/34/0376. For full prescribing information, refer to the package insert approved by the Medicines Control Council, July 2009.
1) Pompeo ACL, et al. A randomised, double blind study comparing the efficacy and tolerability of controlled release Doxazosin and tamsulosin in the treatment of benign prostatic hyperplasia. Int J. Clin Pract Oct 2006;60(10):1172-
1177. 2)Kirby RS, et al. A Combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia. British
Journal of Urology International 2001 Feb;87(3):192-200. 3) Carzin XL package insert.4) Vs. Doxazosin XL originator 4 mg modified release formulation. Department of Health website - Accessed 21/05/2015.
CLXC73/01/2015
DOXAZOSIN 4 mg
onset for consistent flow1 Slower
A slower onset of action vs IR formulations to allow
fewer titration steps and to minimize side-effects2.
Effective treatment for urinary outflow obstruction
and BPH symptoms3.
Safe BPH treatment for normotensive and
hypertensive patients3.
Carzin XL , the extended release doxazosin offers:
SAVING4
% 50 MORE THAN
A Lupin Group Company